Gil Omenn

Q: What Schools Are Affiliated With Gil Omenn

Gil Omenn is affiliated with the following schools: Andrews University, University of Michigan, Princeton University, University of Washington, Massachusetts General Hospital, Harvard University

Gil Omenn's AcademicInfluence.com Rankings

Gil Omenn

Biology

#3519

World Rank

#5372

Historical Rank

#1419

USA Rank

Genetics

#304

World Rank

#357

Historical Rank

#137

USA Rank

biology Degrees

Gil Omenn

Philosophy

#3719

World Rank

#5955

Historical Rank

#1152

USA Rank

Logic

#1354

World Rank

#2085

Historical Rank

#406

USA Rank

philosophy Degrees

Download Badge

Biology
Philosophy

Gil Omenn's Degrees

Masters Medicine Harvard University

Why Is Gil Omenn Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Gilbert S. Omenn is an American medical doctor and researcher. He currently is the Harold T. Shapiro Distinguished University Professor at the University of Michigan; professor of Computational medicine & bioinformatics, Molecular medicine & genetics, Human genetics, and Public health; and the Director of the UM Center for Computational Medicine & Bioinformatics. He is the discover of Omenn syndrome, a genetic disorder that is fatal in infancy unless treated. Omenn has served as editor of the Annual Review of Public Health from 1990–1996. and as president of the American Association for the Advancement of Science . He has published more than 600 peer-reviewed papers and reviews and is the author or editor of 18 books.

(See a Problem?)

Gil Omenn's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. (1995) (3845)
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. (1996) (3479)
ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination (2014) (2398)
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression (2009) (1988)
Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. (2002) (1883)
Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. (1996) (1209)
Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database (2005) (766)
A common open representation of mass spectrometry data and its application to proteomics research (2004) (764)
Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans. (1981) (445)
A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlas* (2011) (428)
The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. (2004) (386)
Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. (1993) (361)
An evaluation, comparison, and accurate benchmarking of several publicly available MS/MS search algorithms: Sensitivity and specificity analysis (2005) (358)
Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data (2012) (339)
Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. (1988) (335)
The Human Proteome Project: Current State and Future Direction (2011) (328)
Evolution of Translational Omics: Lessons Learned and the Path Forward (2013) (319)
Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study (2006) (309)
A wellness study of 108 individuals using personal, dense, dynamic data clouds (2017) (296)
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma (2019) (283)
FAMILIAL RETICULOENDOTHELIOSIS WITH EOSINOPHILIA. (1965) (283)
Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. (2006) (283)
The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome (2012) (281)
The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. (1994) (279)
Meeting Report: Hazard Assessment for Nanoparticles—Report from an Interdisciplinary Workshop (2007) (236)
Making evolutionary biology a basic science for medicine (2010) (207)
Proteogenomic Characterization of Endometrial Carcinoma (2020) (194)
Systematic comparison of the human saliva and plasma proteomes (2009) (194)
Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. (2008) (189)
Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET). (2003) (179)
Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats. (1990) (177)
Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis (2005) (175)
Metscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks (2010) (173)
Chemoprevention of lung cancer: the rise and demise of beta-carotene. (1998) (168)
Preventing coronary heart disease: B vitamins and homocysteine. (1998) (167)
Human Proteinpedia enables sharing of human protein data (2008) (164)
The Human Plasma Proteome Draft of 2017: Building on the Human Plasma PeptideAtlas from Mass Spectrometry and Complementary Assays. (2017) (156)
ConceptGen: a gene set enrichment and gene set relation mapping tool (2010) (155)
The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. (2003) (154)
Blood metabolome predicts gut microbiome α-diversity in humans (2019) (151)
The messenger under attack -- intimidation of researchers by special-interest groups. (1997) (150)
miRmine: a database of human miRNA expression profiles (2017) (148)
Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: Systematic variation between sample types and calibration of mass spectrometry data (2005) (145)
Human Proteome Project Mass Spectrometry Data Interpretation Guidelines 2.1. (2016) (144)
Strategy and planning for chemopreventive drug development: Clinical development plans II (1994) (141)
The Human Proteome Organization Plasma Proteome Project pilot phase: Reference specimens, technology platform comparisons, and standardized data submissions and analyses (2004) (140)
Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. (2004) (138)
Metrics for the Human Proteome Project 2013-2014 and strategies for finding missing proteins. (2014) (138)
Standard guidelines for the chromosome-centric human proteome project. (2012) (136)
NGSQC: cross-platform quality analysis pipeline for deep sequencing data (2010) (134)
Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate Cancer* (2009) (134)
Information value of the rodent bioassay (1988) (131)
Hyperparathyroidism associated with malignant tumors of nonparathyroid origin (1969) (131)
Novel gene and gene model detection using a whole genome open reading frame analysis in proteomics (2006) (130)
Intact-protein-based High-resolution Three-dimensional Quantitative Analysis System for Proteome Profiling of Biological Fluids* (2005) (129)
State of the human proteome in 2013 as viewed through PeptideAtlas: comparing the kidney, urine, and plasma proteomes for the biology- and disease-driven Human Proteome Project. (2014) (128)
Restricted activity days among older adults. (1992) (118)
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. (2021) (118)
Personalized Exposure Assessment: Promising Approaches for Human Environmental Health Research (2005) (116)
Grand Challenges and Great Opportunities in Science, Technology, and Public Policy (2006) (110)
The association of Waardenburg syndrome and Hirschsprung megacolon. (1979) (108)
Medicine Needs Evolution (2006) (107)
Older adults and smoking. (1992) (105)
Current perspective on the global and United States cancer burden attributable to lifestyle and environmental risk factors. (2013) (103)
Characterization of KRAS rearrangements in metastatic prostate cancer. (2011) (102)
Proteogenomic characterization of pancreatic ductal adenocarcinoma (2021) (101)
Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-Induced epithelial-mesenchymal transition. (2009) (101)
The biology/disease-driven human proteome project (B/D-HPP): enabling protein research for the life sciences community. (2013) (99)
A high-stringency blueprint of the human proteome (2020) (98)
Males and females. (1976) (97)
Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future (2007) (95)
Modification of the single tryptophan residue of staphylococcal nuclease by a new mild oxidizing agent. (1970) (94)
Recommendations for Mass Spectrometry Data Quality Metrics for Open Access Data (Corollary to the Amsterdam Principles)* (2011) (93)
Metrics for the Human Proteome Project 2015: Progress on the Human Proteome and Guidelines for High-Confidence Protein Identification. (2015) (92)
Research, innovation, and university-industry linkages. (1980) (92)
Cost-effectiveness of short-term tests for carcinogenicity (1986) (90)
Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity (2003) (89)
Diagnostic evaluation of headache. Impact of computerized tomography and cost-effectiveness. (1980) (89)
Strategies for plasma proteomic profiling of cancers (2006) (88)
Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk. (2001) (86)
COMMITTEE ON THE REVIEW OF OMICS-BASED TESTS FOR PREDICTING PATIENT OUTCOMES IN CLINICAL TRIALS (2012) (86)
The relative merits of population-based and targeted prevention strategies. (2008) (86)
CIDO, a community-based ontology for coronavirus disease knowledge and data integration, sharing, and analysis (2020) (84)
A functional annotation of subproteomes in human plasma (2005) (84)
VO: Vaccine Ontology (2009) (84)
Epigenetics: relevance and implications for public health. (2014) (83)
Integrated Expression Profiling and ChIP-seq Analyses of the Growth Inhibition Response Program of the Androgen Receptor (2009) (83)
Mass Spectrometry-Based Plasma Proteomics: Considerations from Sample Collection to Achieving Translational Data (2019) (83)
A first step toward completion of a genome-wide characterization of the human proteome. (2013) (83)
Association of food frequency questionnaire estimates of vitamin A intake with serum vitamin A levels. (1988) (82)
International Electronic Health Record-Derived COVID-19 Clinical Course Profiles: The 4CE Consortium (2020) (81)
Phosphoglycerate mutase isozyme marker for tissue differentiation in man. (1974) (80)
Development and validation of sandwich ELISA microarrays with minimal assay interference. (2008) (79)
An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer (2009) (79)
The emerging era of genomic data integration for analyzing splice isoform function. (2014) (79)
Molecular neurobiology. (1983) (78)
Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer. (2009) (78)
A proteogenomic portrait of lung squamous cell carcinoma (2021) (77)
The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers. (1993) (77)
Predictors of lung cancer among asbestos-exposed men in the {beta}-carotene and retinol efficacy trial. (2005) (76)
A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system (2005) (76)
State of the Human Proteome in 2014/2015 As Viewed through PeptideAtlas: Enhancing Accuracy and Coverage through the AtlasProphet. (2015) (76)
Systematically Differentiating Functions for Alternatively Spliced Isoforms through Integrating RNA-seq Data (2013) (74)
Biotechnology and Biodegradation (1990) (72)
Congenital adrenal hyperplasia. II. Cognitive and behavioral studies (1975) (72)
The protective effect of beta-carotene and retinol on ventilatory function in an asbestos-exposed cohort. (1997) (70)
Metrics for the Human Proteome Project 2016: Progress on Identifying and Characterizing the Human Proteome, Including Post-Translational Modifications. (2016) (69)
Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells. (2009) (68)
Immunology and genetics of type 1 diabetes. (2008) (68)
Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET). (1993) (67)
International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium (2020) (66)
HIV infection reveals widespread expansion of novel centromeric human endogenous retroviruses (2013) (65)
Analysis of Tumor-Host Interactions by Gene Expression Profiling of Lung Adenocarcinoma Xenografts Identifies Genes Involved in Tumor Formation (2005) (65)
Humoral Response Profiling Reveals Pathways to Prostate Cancer Progression*S (2008) (64)
Considering the Case for Vitamin B12 Fortification of Flour (2010) (64)
Predictive identification of hypersusceptible individuals. (1982) (64)
Exploring the Human Plasma Proteome (2005) (63)
Proteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancers. (2010) (62)
Progress on Identifying and Characterizing the Human Proteome: 2018 Metrics from the HUPO Human Proteome Project. (2018) (61)
New and improved proteomics technologies for understanding complex biological systems: Addressing a grand challenge in the life sciences (2012) (61)
The association between participant characteristics and serum concentrations of beta-carotene, retinol, retinyl palmitate, and alpha-tocopherol among participants in the Carotene and Retinol Efficacy Trial (CARET) for prevention of lung cancer. (1996) (58)
Alternative Splice Variants, a New Class of Protein Cancer Biomarker Candidates: Findings in Pancreatic Cancer and Breast Cancer with Systems Biology Implications (2010) (58)
Data management and preliminary data analysis in the pilot phase of the HUPO Plasma Proteome Project (2005) (57)
Quest for Missing Proteins: Update 2015 on Chromosome-Centric Human Proteome Project. (2015) (55)
Evolution and public health (2009) (55)
Identifying Inhibitors of Epithelial-Mesenchymal Transition by Connectivity Map–Based Systems Approach (2011) (55)
Coupled Global and Targeted Proteomics of Human Embryonic Stem Cells during Induced Differentiation*S (2008) (55)
Human Proteome Project Mass Spectrometry Data Interpretation Guidelines 3.0 (2019) (55)
Development of data representation standards by the human proteome organization proteomics standards initiative (2015) (54)
Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice (2003) (53)
Progress on the HUPO Draft Human Proteome: 2017 Metrics of the Human Proteome Project. (2017) (53)
The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with asbestos-exposed workers. (1993) (53)
Proteomic Interrogation of Androgen Action in Prostate Cancer Cells Reveals Roles of Aminoacyl tRNA Synthetases (2009) (52)
Do we want our data raw? Including binary mass spectrometry data in public proteomics data repositories (2005) (52)
Identification, characterization, and control of potential human carcinogens: a framework for Federal decision-making. (1980) (51)
Proteomics Approaches to Identify Tumor Antigen Directed Autoantibodies as Cancer Biomarkers (2004) (51)
The effect of long-term beta-carotene and vitamin A administration on serum concentrations of alpha-tocopherol. (1994) (50)
Contribution of environmental fibers to respiratory cancer. (1986) (49)
Ontology-Based Combinatorial Comparative Analysis of Adverse Events Associated with Killed and Live Influenza Vaccines (2012) (49)
Functional implications of structural predictions for alternative splice proteins expressed in Her2/neu-induced breast cancers. (2011) (48)
Physical activity in relation to all-site and lung cancer incidence and mortality in current and former smokers. (2004) (48)
Who holds the stakes? A case study of stakeholder identification at two nuclear weapons production sites (1995) (48)
A common uptake system for serotonin and dopamine in human platelets. (1978) (48)
Restricted variation in the glycolytic enzymes of human brain and erythrocytes. (1973) (48)
A gel-based proteomic comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic brain injury. (2007) (48)
Regulation of the Human Endogenous Retrovirus K (HML-2) Transcriptome by the HIV-1 Tat Protein (2014) (47)
Advancement of Biomarker Discovery and Validation through the HUPO Plasma Proteome Project (2004) (47)
Isolation of Mutants of Staphylococcus aureus Lacking Extracellular Nuclease Activity (1970) (47)
Evolutionary molecular medicine (2012) (47)
Psychosocial predictors of outcome in a worksite smoking cessation program. (1989) (46)
Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework (2017) (46)
The human proteome – a scientific opportunity for transforming diagnostics, therapeutics, and healthcare (2012) (45)
Healthcare information technology and economics (2013) (45)
Future research directions in cancer ecogenetics. (1991) (45)
Implications of DRGs for clinicians. (1984) (44)
Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers. (1996) (43)
Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer. (2013) (42)
Environmental Biotechnology. Reducing Risks from Environmental Chemicals Through Biotechnology. Basic Life Sciences Vol. 45 (1988) (42)
Progress on Identifying and Characterizing the Human Proteome: 2018-2019 Metrics from the HUPO Human Proteome Project. (2019) (41)
What accounts for the association of vegetables and fruits with lower incidence of cancers and coronary heart disease? (1995) (41)
Species Differences in Serum Paraoxonase Correlate with Sensitivity to Paraoxon Toxicity (1987) (41)
A new class of protein cancer biomarker candidates: differentially expressed splice variants of ERBB2 (HER2/neu) and ERBB1 (EGFR) in breast cancer cell lines. (2014) (41)
Proteomics, human proteome project, and chromosomes. (2011) (41)
Clinical development plans for cancer chemopreventive agents (1996) (41)
The degree of roentgenographic parenchymal opacities attributable to smoking among asbestos-exposed subjects. (1990) (40)
Correlation between respiratory symptoms and pulmonary function in asbestos-exposed workers. (1993) (40)
THE HUPO Human Plasma Proteome Project (2007) (39)
Immunochemical localization of parathyroid hormone in cancer tissue from patients with ectopic hyperparathyroidism. (1974) (39)
A randomized comparison of Worksite-sponsored smoking cessation programs. (1988) (39)
Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K–Related Sequences (2015) (39)
EVOLUTION AND MEDICINE IN UNDERGRADUATE EDUCATION: A PRESCRIPTION FOR ALL BIOLOGY STUDENTS (2012) (39)
Ectopic hormone syndromes associated with tumors in childhood. (1971) (39)
Fractionation of Antibodies against Staphylococcal Nuclease on ‘Sepharose’ Immunoadsorbents (1970) (39)
Toward more transparent and reproducible omics studies through a common metadata checklist and data publications. (2014) (39)
Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heightens the risk of type 1 diabetes. (2010) (38)
Congenital adrenal hyperplasia. I. Family studies of IQ (1975) (38)
What Every Reader Should Know About Studies Using Electronic Health Record Data but May Be Afraid to Ask (2021) (38)
A chromosome-centric human proteome project (C-HPP) to characterize the sets of proteins encoded in chromosome 17. (2013) (38)
Genetic variability in responses to chemical exposure (1984) (38)
Launching the C-HPP neXt-CP50 Pilot Project for Functional Characterization of Identified Proteins with No Known Function. (2018) (38)
Epithelial-mesenchymal transition-associated secretory phenotype predicts survival in lung cancer patients. (2014) (37)
Computed tomography in patients with cerebrovascular disease: impact of a new technology on patient care. (1978) (37)
Micronutrients (vitamins and minerals) as cancer-preventive agents. (1996) (37)
“Topological Significance” Analysis of Gene Expression and Proteomic Profiles from Prostate Cancer Cells Reveals Key Mechanisms of Androgen Response (2010) (37)
The strategy, organization, and progress of the HUPO Human Proteome Project. (2014) (36)
HUMAN PHOSPHOGLYCERATE MUTASE: ISOZYME MARKER FOR MUSCLE DIFFERENTIATION AND FOR NEOPLASIA (1975) (36)
Distinct splice variants and pathway enrichment in the cell-line models of aggressive human breast cancer subtypes. (2014) (36)
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma (2020) (36)
Genetic Predisposition Impacts Clinical Changes in a Lifestyle Coaching Program (2019) (35)
Standards for plasma and serum proteomics in early cancer detection: a needs assessment report from the national institute of standards and technology--National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18-19, 2005. (2006) (35)
Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam principles) (2012) (35)
Genetic Control of Environmental Pollutants (1984) (35)
Usher syndrome in four hard-of-hearing siblings. (1978) (35)
Occupational hazards to health care workers: report of a conference. (1984) (35)
Fossil porphyrins: uncomplexed chlorins in a triassic sediment (1961) (34)
Dyslexia: search for phenotypic and genetic heterogeneity. (1978) (34)
The temporal pattern of reduction of mortality risk after smoking cessation. (1990) (34)
SRM targeted proteomics in search for biomarkers of HCV‐induced progression of fibrosis to cirrhosis in HALT‐C patients (2012) (33)
The histocompatibility system and human disease. (1976) (32)
Ectopic polypeptide hormone production by tumors. (1970) (32)
Dermatomyositis and malignant effusions: rare manifestations of carcinoma of the prostate. (1968) (32)
Prenatal prediction in myotonic dystrophy: Guidelines for genetic counseling (1973) (32)
Prospects for radiographic intrauterine diagnosis--the syndrome of thrombocytopenia with absent radii. (1973) (31)
The role of the histone H3 variant CENPA in prostate cancer (2020) (31)
Advances and Utility of the Human Plasma Proteome. (2021) (31)
Metab2MeSH: annotating compounds with medical subject headings (2012) (31)
Innovations in proteomic profiling of cancers: alternative splice variants as a new class of cancer biomarker candidates and bridging of proteomics with structural biology. (2013) (31)
Evidence for excess colorectal cancer incidence among asbestos-exposed men in the Beta-Carotene and Retinol Efficacy Trial. (2005) (31)
Revisiting the identification of canonical splice isoforms through integration of functional genomics and proteomics evidence (2014) (31)
Auditory and Visual Evoked Responses in Children with Familial Reading Disabilities (1977) (31)
Genetic issues in the syndrome of minimal brain dysfunction. (1973) (30)
Discovery of cancer biomarkers through the use of mouse models. (2007) (30)
Research on The Human Proteome Reaches a Major Milestone: >90% of Predicted Human Proteins Now Credibly Detected, according to the HUPO Human Proteome Project. (2020) (30)
Genome-Wide Functional Annotation of Human Protein-Coding Splice Variants Using Multiple Instance Learning. (2016) (29)
Potential clinical and economic effects of homocyst(e)ine lowering. (2000) (29)
Stopping the active intervention: CARET. (2003) (29)
Electrocardiogram changes suggestive od coronary artery disease in pneumothorax. Their reversibility with upright posture. (1970) (29)
Public health genetics: an emerging interdisciplinary field for the post-genomic era. (2000) (29)
A compatible exon-exon junction database for the identification of exon skipping events using tandem mass spectrum data (2008) (29)
Expansion of a novel endogenous retrovirus throughout the pericentromeres of modern humans (2015) (29)
Lobe of origin and histologic type of lung cancer associated with asbestos exposure in the Carotene and Retinol Efficacy Trial (CARET). (1997) (29)
Functional Networks of Highest-Connected Splice Isoforms: From The Chromosome 17 Human Proteome Project. (2015) (28)
Risk Estimation and Value‐of‐Information Analysis for Three Proposed Genetic Screening Programs for Chronic Beryllium Disease Prevention (2000) (28)
Multi-Omic Biological Age Estimation and Its Correlation With Wellness and Disease Phenotypes: A Longitudinal Study of 3,558 Individuals. (2019) (28)
The CARET asbestos-exposed cohort: baseline characteristics and comparison to other asbestos-exposed cohorts. (1997) (27)
Prevention and the reforming U.S. health care system: changing roles and responsibilities for public health. (1996) (27)
Longitudinal analysis reveals transition barriers between dominant ecological states in the gut microbiome (2020) (27)
Chemoprevention of lung cancer is proving difficult and frustrating, requiring new approaches. (2000) (27)
Prevention and the elderly: appropriate policies. (1990) (26)
Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas (2017) (26)
A BIOCHEMICAL AND GENETIC APPROACH TO ALCOHOLISM (1972) (26)
Genome-wide proteomics, Chromosome-Centric Human Proteome Project (C-HPP), part II. (2014) (25)
CARET, the β‐carotene and retinol efficacy trial to prevent lung cancer in asbestos‐exposed workers and in smokers (1991) (25)
Accurate prediction of personalized olfactory perception from large-scale chemoinformatic features (2017) (25)
7th HUPO World Congress of Proteomics: Launching the Second Phase of the HUPO Plasma Proteome Project (PPP‐2) 16–20 August 2008, Amsterdam, The Netherlands (2009) (25)
International Analysis of Electronic Health Records of Children and Youth Hospitalized With COVID-19 Infection in 6 Countries (2021) (25)
Nucleome Analysis Reveals Structure–Function Relationships for Colon Cancer (2017) (25)
Comparisons of serotonin uptake by blood platelets and brain synaptosomes (1978) (25)
Structure and Protein Interaction-Based Gene Ontology Annotations Reveal Likely Functions of Uncharacterized Proteins on Human Chromosome 17. (2018) (24)
Beneficial Six-Year Outcome of Smoking Cessation in Older Men and Women with Coronary Artery (1989) (24)
Evolving phenotypes of non-hospitalized patients that indicate long COVID (2021) (24)
Cellular, transcriptomic and isoform heterogeneity of breast cancer cell line revealed by full-length single-cell RNA sequencing (2020) (23)
Effect of shellfish consumption on cholesterol absorption in normolipidemic men. (1987) (23)
Tiered Human Integrated Sequence Search Databases for Shotgun Proteomics. (2016) (23)
Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET) (2005) (23)
A mouse plasma peptide atlas as a resource for disease proteomics (2008) (23)
Streamlining IRB review in multisite trials through single-study IRB Cooperative Agreements: experience of the Beta-Carotene and Retinol Efficacy Trial (CARET). (2002) (22)
Participation and adherence among older men and women recruited to the Beta-Carotene and Retinol Efficacy trial (CARET). (1991) (22)
Advances in the Chromosome-Centric Human Proteome Project: looking to the future (2017) (22)
BiomarkerDigger: A versatile disease proteome database and analysis platform for the identification of plasma cancer biomarkers (2009) (22)
Identification of Organ-Enriched Protein Biomarkers of Acute Liver Injury by Targeted Quantitative Proteomics of Blood in Acetaminophen- and Carbon-Tetrachloride-Treated Mouse Models and Acetaminophen Overdose Patients. (2016) (22)
Overview of the symposium on public health significance of genomics and eco-genetics. (2010) (22)
Toward More Transparent and Reproducible Omics Studies Through a Common Metadata Checklist and Data Publications (2013) (22)
Identifying the Zoonotic Origin of SARS-CoV-2 by Modeling the Binding Affinity between the Spike Receptor-Binding Domain and Host ACE2 (2020) (22)
Physical, morphological, and chemical studies of dusts derived from the machining of composite-epoxy materials. (1988) (22)
Long-term vitamin A does not produce clinically significant hypertriglyceridemia: results from CARET, the beta-carotene and retinol efficacy trial. (1994) (21)
Predictions of rodent carcinogenicity testing results: Interpretation in light of the lave‐omenn value‐of‐information model (1995) (21)
Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome. (2015) (21)
Linking MedDRA®-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors (2016) (21)
Highlights of the Biology and Disease-driven Human Proteome Project, 2015-2016. (2016) (21)
Negative ion mass spectra of benzene, naphthalene, and anthracene. A new technique for obtaining relatively intense and reproducible negative ion mass spectra. (1968) (20)
WaveletQuant, an improved quantification software based on wavelet signal threshold de-noising for labeled quantitative proteomic analysis (2010) (20)
Immunochemistry of staphylococcal nuclease. I. Physical, enzymatic, and immunological studies of chemically modified derivatives. (1970) (20)
Progress Identifying and Analyzing the Human Proteome: 2021 Metrics from the HUPO Human Proteome Project. (2021) (20)
Validation of an Internationally Derived Patient Severity Phenotype to Support COVID-19 Analytics from Electronic Health Record Data (2021) (20)
Stunted Lives, Stagnant Economies: Poverty, Disease, and Underdevelopment (1998) (20)
Toward Completion of the Human Proteome Parts List: Progress Uncovering Proteins That Are Missing or Have Unknown Function and Developing Analytical Methods (2018) (20)
Putting environmental risks in a public health context. (1996) (20)
Inborn errors of metabolism: Clues to understanding human behavioral disorders (1976) (19)
Prenatal diagnosis of genetic disorders. (1978) (19)
A Network of Splice Isoforms for the Mouse (2016) (19)
A Blinded Testing of Function Annotation for uPE1 Proteins by the I-TASSER/COFACTOR Pipeline Using the 2018-2019 Additions to neXtProt and the CAFA3 Challenge. (2019) (19)
Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam Principles). (2012) (19)
GENETIC APPROACHES TO THE SYNDROME OF MINIMAL BRAIN DYSFUNCTION * (1973) (19)
Caring for the community: the role of partnerships. (1999) (19)
Rapid molecular assays to study human centromere genomics (2017) (19)
Functions of Essential Genes and a Scale-Free Protein Interaction Network Revealed by Structure-Based Function and Interaction Prediction for a Minimal Genome. (2021) (19)
Interpretations of the Linxian vitamin supplement chemoprevention trials. (1998) (19)
The Impact of Computed Tomography on the Care of Patients with Suspected Brain Tumor (1977) (18)
Modeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responses. (2009) (18)
Research cost analyses to aid in decision making in the conduct of a large prevention trial, CARET. Carotene and Retinol Efficacy Trial. (1993) (18)
Strategies for recruitment to a population-based lung cancer prevention trial: the CARET experience with heavy smokers. Beta-Carotene and Retinol Efficacy Trial. (1998) (18)
Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8. (2010) (18)
Data management and data integration in the HUPO plasma proteome project. (2011) (18)
Nature and nurture in alcoholism (1972) (18)
Micronutrient assay for cancer prevention clinical trials: serum retinol, retinyl palmitate, alpha-carotene, and beta-carotene with the use of high-performance liquid chromatography. (1987) (17)
MetDisease - connecting metabolites to diseases via literature (2014) (17)
Ethical Principles, Constraints, and Opportunities in Clinical Proteomics (2021) (17)
An Omics Perspective on Cancer Research (2011) (17)
ELECTROPHORETIC PROFILES OF AQUEOUS‐SOLUBLE PROTEINS OF HUMAN CEREBRAL CORTEX: POPULATION AND DEVELOPMENTAL CHARACTERISTICS 1 (1974) (17)
Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease (2021) (17)
Clinical Pathways: Recommendations for Putting Patients at the Center of Value-Based Care (2017) (17)
Pancoast syndrome due to metastatic carcinoma from the uterine cervix. (1971) (17)
Plasma proteomics, the Human Proteome Project, and cancer-associated alternative splice variant proteins. (2014) (17)
Assessing the risk assessment paradigm. (1995) (17)
For the Health of a Nation: A Shared Responsibility (1990) (16)
Prospects for pharmacogenetics and ecogenetics in the new millennium. (2001) (16)
Immunology and genetics. (1972) (16)
Combination of Multiple Spectral Libraries Improves the Current Search Methods Used to Identify Missing Proteins in the Chromosome-Centric Human Proteome Project. (2015) (16)
Reflections on the HUPO Human Proteome Project, the Flagship Project of the Human Proteome Organization, at 10 Years (2021) (16)
International collaboration in clinical chemistry and laboratory medicine: the Human Proteome Organization (HUPO) Plasma Proteome Project (2004) (16)
Discriminatory Aspects of Pre-employment Screening: Low-Back X-ray Examinations in the Railroad Industry (1979) (16)
Studies of polypeptide structure by fluorescence techniques. III. Interaction between dye and macromolecule in fluorescent conjugates (1967) (16)
The NIH National Center for Integrative Biomedical Informatics (NCIBI) (2012) (16)
Recent Advances in the Chromosome-Centric Human Proteome Project: Missing Proteins in the Spot Light. (2015) (16)
International Comparisons of Harmonized Laboratory Value Trajectories to Predict Severe COVID-19: Leveraging the 4CE Collaborative Across 342 Hospitals and 6 Countries: A Retrospective Cohort Study (2020) (15)
Longitudinal pattern of reported respiratory symptoms and accelerated ventilatory loss in asbestos-exposed workers. (1996) (15)
Identification of alternatively spliced transcripts using a proteomic informatics approach. (2011) (15)
MIsoMine: a genome-scale high-resolution data portal of expression, function and networks at the splice isoform level in the mouse (2015) (15)
8 – Controlled Testing and Monitoring Methods for Microorganisms (1986) (15)
Recent Workshops of the HUPO Human Plasma Proteome Project (HPPP): A bridge with the HUPO CardioVascular Initiative and the emergence of SRM targeted proteomics (2011) (15)
A Scientific Supercourse (2006) (15)
Measurement of organ-specific and acute-phase blood protein levels in early Lyme disease (2019) (15)
Chapter 7 – Biochemical Genetics and the Evolution of Human Behavior (1972) (15)
Monozygotic twins with Huntington's disease in a family expressing the rigid variant (1975) (15)
Scientific and cost-effectiveness criteria in selecting batteries of short-term tests. (1988) (15)
Progress in the Chromosome-Centric Human Proteome Project as Highlighted in the Annual Special Issue IV. (2016) (15)
Structural Bioinformatics Inspection of neXtProt PE5 Proteins in the Human Proteome. (2015) (15)
Hazards for health care workers. (1988) (14)
Carotene and retinol efficacy trial: lung cancer chemoprevention trial in heavy cigarette smokers and asbestos-exposed workers. CARET Coinvestigators and Staff. (1992) (14)
7 th HUPO World Congress of Proteomics: Launching the Second Phase of the HUPO Plasma Proteome Project (PPP-2) (2009) (14)
Seizing the Opportunities (2006) (14)
Studies of the aromatic circular dichroism of Staphylococcal nuclease. (1969) (14)
Studies on the Helix-Coil Transition by Polarization of Fluorescence Measurements1 (1965) (14)
Platelet uptake of serotonin and dopamine in Huntington disease (1978) (14)
Recruitment for the beta-carotene and retinol efficacy trial (CARET) to prevent lung cancer in smokers and asbestos-exposed workers. (1992) (14)
Hormone syndromes associated with bronchogenic carcinoma. Clues to histologic type. (1970) (13)
Multiomic blood correlates of genetic risk identify presymptomatic disease alterations (2020) (13)
Assessment of Human Cancer Risk: Challenges for Alternative Approaches (2001) (13)
Clearing the air: reforming the Clean Air Act. [Monograph] (1981) (13)
Myotonic dystrophy (1975) (13)
On the Significance of “The Red Book” in the Evolution of Risk Assessment and Risk Management (2003) (13)
Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia. (2002) (13)
Highlights of B/D‐HPP and HPP Resource Pillar Workshops at 12th Annual HUPO World Congress of Proteomics (2014) (13)
Human lung cancer chemoprevention strategies: Parker B. Francis lecture. (2004) (13)
The genomic era: a crucial role for the public health sciences. (2000) (12)
Advances in genetics and immunology: the importance of basic research to prevention of occupational diseases. (1984) (12)
Progress and Future Direction of Chromosome-Centric Human Proteome Project. (2017) (12)
Use of ultrasound in the prenatal exclusion of primary microcephaly. (1974) (12)
The use of radiographic visualization for prenatal diagnosis. (1977) (12)
Immunochemistry of staphylococcal nuclease. II. Inhibition and binding studies with sequence fragments. (1970) (12)
Prenatal prediction in myotonic dystrophy: guidelines for genetic counseling. (1973) (12)
DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease risk. (2021) (12)
Healing the Schism: Epidemiology, Medicine, and the Public's Health (1993) (12)
De Novo RNA Tertiary Structure Prediction at Atomic Resolution Using Geometric Potentials from Deep Learning (2022) (12)
Novel Bioinformatics Method for Identification of Genome-Wide Non-Canonical Spliced Regions Using RNA-Seq Data (2014) (12)
Comment: genetics and public health. (1996) (12)
Distinguishing Admissions Specifically for COVID-19 From Incidental SARS-CoV-2 Admissions: National Retrospective Electronic Health Record Study (2022) (12)
Contributions to behavior-genetic analysis. The mouse as a prototype (1971) (12)
A Model for Selecting Short-Term Tests of Carcinogenicity (1983) (11)
The Human Plasma and Serum Proteome (2007) (11)
Effects of Incentive Items on Participation in a Randomized Chemoprevention Trial (2000) (11)
Computational Inferences of the Functions of Alternative/Noncanonical Splice Isoforms Specific to HER2+/ER-/PR- Breast Cancers, a Chromosome 17 C-HPP Study. (2015) (11)
Impact of computed tomography on the care of patients with suspected hydrocephalus. (1978) (11)
Preanalytical Variables for Plasma and Serum Proteome Analyses (2011) (11)
MUCIN GLYCOSYLATION IS ALTERED BY PRO-INFLAMMATORY SIGNALING IN PANCREATIC-CANCER CELLS (2008) (11)
Identifying zoonotic origin of SARS-CoV-2 by modeling the binding affinity between Spike receptor-binding domain and host ACE2 (2020) (11)
Human malic enzyme: High-frequency polymorphism of the mitochondrial form (1972) (11)
Systematic Proteogenomic Approach To Exploring a Novel Function for NHERF1 in Human Reproductive Disorder: Lessons for Exploring Missing Proteins. (2017) (11)
The crucial role of the public health sciences in the postgenomic era (2002) (10)
Genetic advances will influence the practice of medicine: Examples from cancer research and care of cancer patients (2002) (10)
A double-blind randomized trial with beta-carotene and retinol in persons at high risk of lung cancer due to occupational asbestos exposures and/or cigarette smoking. (1988) (10)
Alcoholism: a pharmacogenetic disorder. (1975) (10)
Validation of a Derived International Patient Severity Phenotype to Support COVID-19 Analytics from Electronic Health Record Data (2020) (10)
Serotonin in Down's Syndrome (1975) (10)
A Meta-Analysis of Plasma Homocysteine as a Risk Factor for Arteriosclerotic Vascular Disease and the Potential Preventive Role of Folic Acid (1997) (9)
Screening Toxic Chemicals: How Accurate Must Tests Be? (1988) (9)
Bioinformatics and systems biology of cancers. (2010) (9)
Multinational Prevalence of Neurological Phenotypes in Patients Hospitalized with COVID-19 (2021) (9)
International electronic health record-derived post-acute sequelae profiles of COVID-19 patients (2022) (9)
Predictors of participant retention in two chemoprevention feasibility trials (1999) (9)
Chromosome 17 Missing Proteins: Recent Progress and Future Directions as Part of the neXt-MP50 Challenge. (2018) (9)
Measurements of gene expression in tissues of normal and dystrophic mice (1978) (9)
The human eye proteome project (2013) (9)
Making Credible Scientific Judgments about Important Health and Ecological Risks and Ways to Efficiently Reduce Those Risks (2011) (9)
The Guide to Community Preventive Services will be influential in academic health centers: education, research and links with practice. (2000) (9)
A comprehensive update on CIDO: the community-based coronavirus infectious disease ontology (2022) (9)
The human proteome project: Current state and future direction. (2011) (9)
Modification of staphylococcal nuclease with nitrophenylsulfenyl halides. (1971) (9)
Rationale and design of cancer chemoprevention studies in Seattle. (1985) (9)
Strategies for Genomic and Proteomic Profiling of Cancers (2016) (9)
Biotechnology and the environment (1986) (9)
International Changes in COVID-19 Clinical Trajectories Across 315 Hospitals and 6 Countries: Retrospective Cohort Study (2021) (9)
Impact of computed tomography on utilization of cerebral angiograms. (1977) (9)
Functional organization of the maternal and paternal human 4D Nucleome (2020) (9)
The role of genetic differences in human susceptibility to pesticides (1987) (8)
Pharmacogenetics: Clinical and Experimental Studies in Man (1975) (8)
SurvMaximin: Robust Federated Approach to Transporting Survival Risk Prediction Models (2022) (8)
A similarity-based approach to leverage multi-cohort medical data on the diagnosis and prognosis of Alzheimer's disease (2018) (8)
Pharmacogenetics and mental disease (1974) (8)
CARET, the beta-carotene and retinol efficacy trial to prevent lung cancer in high-risk populations. (1991) (8)
Multilayer and Multimetric Quality Control: The Supercourse (2010) (8)
Dimensions of care of the dying patient. (1995) (8)
Untargeted longitudinal analysis of a wellness cohort identifies markers of metastatic cancer years prior to diagnosis (2020) (8)
Studies of polypeptide structure by fluorescence techniques. II. The effect of temperature and viscosity on the polarization of fluorescence of synthetic polypeptide-dye conjugates. (1966) (8)
Advances of the HUPO Human Proteome Project with broad applications for life sciences research (2017) (7)
Genetic counseling for adoptees at risk for specific inherited disorders. (1980) (7)
The HUPO Plasma Proteome Project: A report from the Munich congress (2006) (7)
Genetics and public health: Historical perspectives and current challenges and opportunities (2009) (7)
From human genome research to personalized health care (2009) (7)
Worksite smoking cessation: a test of two programs. (1987) (7)
Report from the 2nd Annual US HUPO Meeting on the HUPO Human Plasma Proteome Project (2006) (7)
Genetic variation of the cytoplasmic and mitochondrial malic enzymes in the monkey Macaca nemestrina (1972) (7)
Chapter 4 Gene–Environment Interactions Eco-Genetics and Toxicogenomics (2013) (7)
A proteogenomic approach to understand splice isoform functions through sequence and expression-based computational modeling (2016) (7)
Clearing the air : reforming the Clean Air Act : a staff paper (1981) (7)
Corrigendum: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression (2013) (7)
Enhancing the role of the scientific expert witness. (1994) (7)
Value-of-information analysis of testing strategies: estimating the effect of uncertainty about the proportion of chemicals that are true human carcinogens. (1990) (7)
Integration of Pharmacogenomics into Medical Practice (2003) (6)
The Role of Intervention Studies in Ascertaining the Contribution of Dietary Factors in Lung Cancer (1988) (6)
Omics-Based Clinical Discovery: Science, Technology, and Applications (2012) (6)
Characteristics of Health Promotion Programs in Federal Worksites: Findings from the Federal Employee Worksite Project (1995) (6)
HUPO Plasma Proteome Project 2007 Workshop Report (2007) (6)
Insights from the First Phosphopeptide Challenge of the MS Resource Pillar of the HUPO Human Proteome Project. (2020) (6)
Biological availability of lead in a paint aerosol. 2. Absorption, distribution and excretion of intratracheally instilled lead paint particles in the rat. (1984) (6)
Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study (2022) (6)
A new look for Medicaid. (1986) (6)
Biorepositories: Let's Not Lose What We Have So Carefully Gathered! (2006) (6)
Prevention policy: perspectives on the critical interaction between research and policy. (1994) (6)
The Impact of Alternative Payment Models on Oncology Innovation and Patient Care (2016) (5)
The proteomes of the human eye, a highly compartmentalized organ (2017) (5)
Toxicogenomics: Principles and Applications (2004) (5)
Ecogenetics: Historical Perspectives (2006) (5)
Exploring the Human Plasma Proteome: OMENN:HUMAN PLASMA PROTEO O-BK (2006) (5)
The new millennium: values, perceptions of risk, and the key roles of science and technology. (2001) (5)
Genetic investigations of alcohol metabolism and of alcoholism. (1988) (5)
Erratum: What accounts for the association of vegetables and fruits with lower incidence of cancers and coronary heart disease? (Annals of Epidemiology (July 1995) 5:4 (335)) (1995) (5)
Prioritizing predictive biomarkers for gene essentiality in cancer cells with mRNA expression data and DNA copy number profile (2018) (5)
Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment (2021) (5)
Enhancing the Teaching of Evolution in Public Health (2011) (5)
Taking university research into the marketplace. (1982) (5)
Standards for Plasma and Serum Protoemics in Early Cancer Detection: A Needs Assessment Report From the NIST-NCI SMART Workshop, August 18-19, 2005 | NIST (2006) (5)
Ontology-based systematic classification and analysis of coronaviruses, hosts, and host-coronavirus interactions towards deep understanding of COVID-19 (2020) (5)
The camel's nose is under the tent: opportunities for prevention associated with the 2003 Medicare Act. (2004) (5)
Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam principles) (2011) (5)
Distinguishing Admissions Specifically for COVID-19 from Incidental SARS-CoV-2 Admissions: A National EHR Research Consortium Study (2022) (5)
Genetic disorders of the endocrine glands. (1972) (5)
3. University-Corporate Relations in Science and Technology: An Analysis of Specific Models (1983) (5)
Human neuron-specific enolase: genetic and developmental studies. (1984) (4)
Solid waste biodegradation by anaerobic digestion: a developing technology in Europe. (1989) (4)
Research, Innovation, and University Industry Linkages : Science (1988) (4)
Environmental Risk Assessment: Relation to Mutagenesis, Teratogenesis, and Reproductive Effects (1983) (4)
Ethnic differences in reactions to drugs and xenobiotics. Susceptibility to occupational and environmental exposures to chemicals. (1986) (4)
Genetics and epidemiology: medical interventions and public policy. (1979) (4)
MI-PVT: A Tool for Visualizing the Chromosome-Centric Human Proteome. (2015) (4)
Psychopharmacogenetics: an overview and new approaches. (1978) (4)
On best practices: The Institute of Medicine scheme for developing, validating, and demonstrating clinical utility of omics‐based diagnostic and predictive tests (2013) (4)
Multinational characterization of neurological phenotypes in patients hospitalized with COVID-19 (2021) (4)
Fossil Chlorins in a Triassic Sediment (1961) (4)
The role of environmental epidemiology in public policy. (1993) (4)
Provide the citizens of New Zealand the miracle of folic acid fortification. (2003) (4)
Improving Health Risk Assessment as a Basis for Public Health Decisions in the 21st Century (2020) (4)
De Novo Protein Fold Design Through Sequence-Independent Fragment Assembly Simulations (2022) (4)
Environmental Biotechnology: Biotechnology Solutions for a Global Environmental Problem, Hazardous Chemical Wastes (1992) (4)
52A Effectiveness of a placebo run-in period in increasing the power of a chemoprevention trial, CARET (1995) (4)
Psychopharmacogenetics: An Overview and New ApproachesIntroduction (1978) (4)
Violence and the politics of research (1983) (4)
ClusterMine: a Knowledge-integrated Clustering Approach based on Expression Profiles of Gene Sets (2018) (4)
Stephen C. Stearns and Ruslan Medzhitov, Evolutionary Medicine (2016) (4)
The 2022 Report on the Human Proteome from the HUPO Human Proteome Project. (2022) (4)
Brain, genetics, and behavior. (1971) (3)
Fabry's disease: the search for a regulator gene mutation in man. (1972) (3)
An assessment of the scientific basis for attempting to define the Dietary Reference Intake for beta carotene. (1998) (3)
International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality (2022) (3)
IsoResolve: predicting splice isoform functions by integrating gene and isoform-level features with domain adaptation (2020) (3)
A landmark systems analysis of prion disease of the brain (2009) (3)
The initiative on Model Organism Proteomes (iMOP) Session September 6, 2011, Geneva, Switzerland (2012) (3)
Strategies for Recruitment to a Population-based Lung Cancer Prevention Trial: The CARET Experience with Heavy Smokers I (2008) (3)
Studies on the Structure of Synthetic Polypeptides in Solution by Polarization of Fluorescence Techniques (1967) (3)
Ketamine’s pharmacogenomic network in human brain contains sub-networks associated with glutamate neurotransmission and with neuroplasticity (2020) (3)
The HUPO Human Proteome Project (HPP), a Global Health Research Collaboration (2012) (3)
Folic Acid Fortification of Food-Reply (1996) (3)
Bioinformatics for High-Throughput Toxico-Epigenomics Studies (2012) (3)
Genetic Engineering: Present and Future (1973) (3)
Modeling the functional relationship network at the splice isoform level through heterogeneous data integration (2014) (3)
Medicare's new payment plan: a mixed blessing. (1985) (3)
Homocyst(e)ine and Coronary Heart Disease (2012) (3)
International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality (2022) (3)
Advances in Identifying and Characterizing the Human Proteome. (2019) (3)
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. (2022) (3)
Legal aspects of human genetics. (1985) (3)
An experimental strategy for quantitative analysis of the humoral immune response to prostate cancer antigens using natural protein microarrays (2007) (3)
Neurochemistry and behavior in man. (1976) (3)
Significance of histocompatibility genes in rheumatology. (1977) (3)
A common uptake mechanism for serotonin and dopamine in human platelets (1977) (3)
Travel report: human genetics of high interest in China. (1980) (3)
Occasional notes. What's behind those block grants in health? (1982) (2)
Reply to "Precision medicine in the clouds" (2018) (2)
Shaping a positive future for academic medicine at Michigan. (2000) (2)
Electrocardiogram Changes Suggestive of Coronary Artery Disease in Pneumothorax (2017) (2)
International Changes in COVID-19 Clinical Trajectories Across 315 Hospitals and 6 Countries: a 4CE Consortium Study (Preprint) (2021) (2)
Genome architecture and transcription data reveal allelic bias during the cell cycle (2020) (2)
Lessons from a fourteen-state study of Medicaid. (1987) (2)
Anhidrotic ectodermal dysplasia with frequent infections and amyloidosis. (1977) (2)
Chemoprevention of Lung Cancer with Retinol/Beta-Carotene (1986) (2)
Special challenges in applying genomics to population health. (2001) (2)
Cancer Chemoprevention with Vitamin A and Beta-Carotene in Populations at High-Risk for Lung Cancer (1987) (2)
A MODEL FOR SELECTING SHORT‐TERM TESTS OF CARCINOGENICITY (1983) (2)
Blood metabolome signature predicts gut microbiome α-diversity in health and disease (2019) (2)
Intrauterine diagnosis and genetic counseling in psychiatry. (1976) (2)
16A The use of incentives to increase participation in a chemoprevention trial (1995) (2)
Challenges facing public health policy. (1993) (2)
Reflections on Developments in Health Promotion in the past Quarter Century from Founding Members of the American Journal of Health Promotion Editorial Board (2011) (2)
Research on antioxidants to prevent cancer or heart disease (1992) (2)
Observations on work force and training needs for assessing environmental health risks. (1988) (2)
Ecogenetics: a view from the U.S. President's Science Advisory office. (1978) (2)
Prenatal prediction of autosomal dominant diseases by linkage studies: myotonic dystrophy (1974) (2)
Preventing injuries, disability, and death at work (starting with vehicles and guns!) (1982) (2)
Annotation of Alternatively Spliced Proteins and Transcripts with Protein-Folding Algorithms and Isoform-Level Functional Networks. (2017) (2)
HUPO 3rd Annual World Congress on Proteomics (2005) (2)
Psychiatry and genetics (1979) (2)
Hospitalizations Associated With Mental Health Conditions Among Adolescents in the US and France During the COVID-19 Pandemic (2022) (2)
Introduction: With a summary of the findings and recommendations of the commission on risk assessment and risk management (1997) (2)
Ratcheting up cancer potency estimates. (2012) (2)
Best Practices for Omics-Based Test Validation Prior to Use for Patient Management Decisions in a Clinical Trial Setting (2012) (2)
Data Standardization and Integration in Collaborative Proteomics Studies (2005) (2)
HEALTH STATUS AND ITS DETERMINANTS IN URBAN POPULATIONS (1998) (2)
A framework for reproductive risk assessment and surveillance. (1984) (2)
Fast and accurate Ab Initio Protein structure prediction using deep learning potentials (2022) (2)
VI. Summary of Proceedings: A. EMERGING OPPORTUNITIES FOR FUTURE RESEARCH AND APPLICATIONS (1981) (1)
CHAPTER 2 – Basic Research as an Investment in the Nation's Future (1984) (1)
Authorship Correction: International Changes in COVID-19 Clinical Trajectories Across 315 Hospitals and 6 Countries: Retrospective Cohort Study (2021) (1)
Gene–Environment Interactions (2012) (1)
Ephraim Katchalski Katzir (2010) (1)
On ethical issues in publishing in the life sciences (2008) (1)
Genetic control mechanisms in man and other mammals. (1970) (1)
Genetic isolation of adoptees. (1980) (1)
Schools of public health. History and progress of federal agencies' health services programs (1991) (1)
Risk Assessment and the Impact of Ecogenetics (2006) (1)
Risk assessment for butadiene: introductory and summary comments. (1996) (1)
Report from a conference on "Genetic Control of Environmental Pollutants". (1984) (1)
TripletGO: Integrating Transcript Expression Profiles with Protein Homology Inferences for High-Accuracy Gene Function Annotations (2021) (1)
Electrophoretic methods for differentiating glycolytic enzymes of mouse and human origin (1971) (1)
Ethical principles, opportunities and constraints in clinical proteomics. (2021) (1)
Genetics and Public Health (2019) (1)
Neurological Diagnoses in Hospitalized COVID-19 Patients Associated With Adverse Outcomes: A Multinational Cohort Study (2022) (1)
Special award lecture: biochemical genetics and psychiatry. (1975) (1)
Changes in laboratory value improvement and mortality rates over the course of the pandemic: an international retrospective cohort study of hospitalised patients infected with SARS-CoV-2 (2022) (1)
Presidential Commission on biomedical ethics launched (1980) (1)
The Northwest Center for Public Health Practice. (1993) (1)
Informative Missingness: What can we learn from patterns in missing laboratory data in the electronic health record? (2022) (1)
Commentary on Scientific Peer Review to Inform Regulatory Decision Making: Roles and Perspectives of Scientists (2006) (1)
Prenatal Diagnosis and Public Policy (1986) (1)
Genetics, Adoption, and the Law (1980) (1)
The human proteome – a scientific opportunity for transforming diagnostics, therapeutics, and healthcare (2012) (1)
Pharmacogenetic studies of monoamine oxidase in human and macaque brain (1976) (1)
Genetic counseling: the search for the adopted child. (1976) (1)
Pilot Phase Results of the Human Proteome Organization Plasma Proteome Project. (2004) (1)
Re-Energizing the Research University. (1982) (1)
Understanding Covid Vaccine Efficacy over Time - Bridging a Gap Between Public Health and Health Care. (2022) (1)
Public Health Context for Nutrigenomics and Personalized Nutrition (2013) (1)
Tons of Toxic Chemicals Above (1989) (1)
Authorship Correction: International Changes in COVID-19 Clinical Trajectories Across 315 Hospitals and 6 Countries: Retrospective Cohort Study (Preprint) (2021) (1)
Computerized Tomographic Scans for Headache-Reply (1980) (1)
Welcome and Introduction (1984) (1)
Barriers and solutions in implementing occupational health and safety services at a large nuclear weapons facility. (2000) (1)
TripletGO: Integrating Transcript Expression Profiles with Protein Homology Inferences for Gene Function Prediction (2022) (1)
The Future: Translation from Discovery to the Clinic – Roles of HUPO and Industry in Biomarker Discovery (2008) (1)
Scientific Controversies: Values in the debate over workplace safety and health: the rancorous rhetoric about regulation (1987) (1)
Abstract B38: Splice variants in aggressive human breast cancer subtypes (2013) (0)
Abstract IA-003: Proteogenomic characterizations of pancreatic ductal adenocarcinoma (2021) (0)
Proteomics in Drug Research Series: Methods and Principals in Medicinal Chemistry. By M. Hamacher, K. Marcus, K. StŸhler, A. van Hall, B. Warscheid and H. E. Meyer (Eds). (2007) (0)
Reviewer Acknowledgment (2013) (0)
National nutrition policy in the United States. (1981) (0)
Maternal and child health (1982) (0)
Genetics of rheumatic diseases. (1977) (0)
Inheritance of creative intelligence (1979) (0)
' s report Title : Deep sequencing analysis of transcription-induced chimeras in human prostate adenocarcinoma and reference samples Version : 3 Date : 25 November 2010 (0)
Human Blood Plasma Proteins: Structure and Function.ByJohann Schaller, Simon Gerber, Urs Kämpfer, Sofia Lejon, and Christian Trachsel. Chichester (United Kingdom) and Hoboken (New Jersey): John Wiley & Sons. $170.00. xi + 526 p.; ill.; index. 978‐0‐470‐01674‐9. 2008. (2009) (0)
Roundtable Discussion: Directions for the Future (1984) (0)
Recognition of ectopic hormone syndromes produced by tumors. (1971) (0)
A high quality human plasma proteome available in the PeptideAtlas (2009) (0)
Genetic approaches to neurobiology (1979) (0)
Title Personalized exposure assessment : promising approaches for human environmental health research (2005) (0)
Positive perceptions in a time of change. Interview by Jane Stein. (1985) (0)
The relevance of the hupo human proteome project for proteomics studies of osteoarthritis (2012) (0)
Biotechnology and the Environment: Research Needs (1987) (0)
Acknowledgment of Contributors (2012) (0)
Royal academy of medicine in Ireland international conference on homocysteine metabolism from basic science to clinical medicine (1995) (0)
Editorial: Pharmacogenetics and mental disease. (1974) (0)
Physician-scientist: Linking science, medicine, and public policy (2011) (0)
WORKSHOP OVERVIEW Risk Characterization: A Bridge to Informed Decision Making1 (1997) (0)
Risk assessment for potentially carcinogenic chemicals (1988) (0)
PLASMA PROTEOME PROFILES ASSOCIATED WITH CANCERS (2006) (0)
Serotonin in essential myoclonus. (1977) (0)
Proteomics in Drug Research. By M. Hamacher, K. Marcus, K. Stühler, A. van Hall, B. Warscheid and H. E. Meyer (Eds). (2007) (0)
Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma (2022) (0)
Pulmonary Infection by PCR in Very Low Birth Weight Neonates with Bronchopulmonary Dysplasia or Mikity Wilson Syndrome Comparative Proteomic Analyses of Normal and Normal Pressure Hydrocephalus in Human Cerebrospinal Fluid (2006) (0)
Evolutionary molecular medicine (2012) (0)
Genetic Predisposition Impacts Clinical Changes in a Lifestyle Coaching Program (2019) (0)
Gene Expression–Based Tests Developed at Duke University and Used in Clinical Trials (2012) (0)
Genetic control of environmental pollutants: A conference review (1986) (0)
Genetic control of environmental pollutants. Basic Life Sciences Volume 28 (1984) (0)
Genetic variation in susceptibility as a key parameter in risk assessment and risk communication: policy aspects. (1996) (0)
A human plasma proteome in the PeptideAtlas with estimated protein concentrations (2009) (0)
Autoantigen IA-2 Heightens the Risk of Type 1 Diabetes Humoral Autoimmunity against the Extracellular Domain of the Neuroendocrine (2010) (0)
Book Reviews: PROTEOMICS IN DRUG RESEARCH. (2007) (0)
Health status and its deter minants in urban populations (1998) (0)
Commentary--medical technologies: a perspective of the Carter administration. (1980) (0)
General Discussion: Environmental Toxicants (1984) (0)
Charles A. Dana Foundation Awards in health (1991) (0)
502 ASSOCIATION OF DELETERIOUS DUOX2 VARIANTS WITH A PRECLINICAL HALLMARK OF DISTURBED MICROBIOTA-IMMUNE HOMEOSTASIS AND RISK OF INFLAMMATORY BOWEL DISEASE (2021) (0)
Pharmacogenetics (1982) (0)
Using Departments of Pathology And (2011) (0)
A new framework for host-pathogen interaction research (2022) (0)
Book ReviewRegulating Health Care: The struggle for control (1981) (0)
A scientific basis for safety (2004) (0)
Ecogenetics, Evolutionary Biology and Human Disease (2007) (0)
Chromosome 17: neXt-MP50 C-HPP Challenge Completed (2019) (0)
Lowering total cholesterol level in the older adult raises serious questions (1994) (0)
Promoting healthy behavior: How much freedom? Whose responsibility? Daniel Callahan, editor, Washington DC: Georgetown University Press, 2000. 192 pages; $19.95 (2001) (0)
A healthier America: health promotion and disease prevention objectives for the year 2000. (1990) (0)
DRGs and hospital readmissions. (1985) (0)
Studies of serum thyroxine-binding globulin (TBG). (1971) (0)
A systems pharmacology approach to model tyrosine kinase inhibitor‐induced cardiotoxicity gene interaction networks (844.17) (2014) (0)
Regulatory frameworks and decisions matter to the development of biotechnology and the approvals for biotechnology products. (1999) (0)
Summary of the work group on reproductive effects (1984) (0)
Preventive medicine and public health: preventing low birth weight. (1985) (0)
Strategies for Genomic and Proteomic Profiling of Cancers (2014) (0)
INTRODUCTION (1972) (0)
Identification of autoantibodies to tumor-derived antigens as candidate biomarkers for the early detection of lung cancer (2005) (0)
Cholesterol screening and cholesterol-lowering regimens examined. (1993) (0)
CRESP at one year (1996) (0)
Engineering: lessons from medical schools. (1982) (0)
Is science sexist (1982) (0)
HUPO 3rd annual World Congress on Proteomics. 25-27th October, 2004, Beijing, China. (2005) (0)
Preface by the Gilbert S. Omenn (1990) (0)
Abstract 3127: Comprehensive proteogenomic characterization of rare kidney tumors (2023) (0)
Editorial: The Human Genome Project (1990) (0)
Fabry's Disease: TheSearchfora Regulator GeneMutation inMan (1972) (0)
Basic Life Sciences. Volume 28. Genetic Control of Environmental Pollutants, Proceedings of a Conference Held at Seattle, Washington on 31 July-3 August 1983, (1984) (0)
Research Universities and the Future: Challenges and Opportunities (2019) (0)
60P Association between food frequency questionnaire estimates and serum concentrations of β-carotene, retinol, retinyl palmitate, and α-tocopherol among participants in the caret lung cancer chemoprevention trial (1994) (0)
INTRODUCTION (1972) (0)
RESPONSE: Chemoprevention or Antichemo- prevention? A Salutary Warning From the β-Carotene Experience (2001) (0)
Genetics and Genomics of Neurobehavioral Disorders.Contemporary Clinical Neuroscience.Edited byGene S Fisch.Totowa (New Jersey): Humana Press. $125.00. x + 428 p; ill.; index. ISBN: 1–58829–045–X. 2003. (2003) (0)
Preface by Gilbert S. Omenn (1993) (0)
VO Modeling and Comparison of Vaccines (2009) (0)
Session 19: Plasma Proteomics I (2004) (0)
Proceed with caution: Predicting genetic risks in the recombinant DNA era (1990) (0)
Pneumococcal antibodies in older tobacco smokers indicate naturally acquired immuntiy (1996) (0)
Medicare's new payment plan (1985) (0)
Introduction: Symposium on Selected Clinical Syndromes Associated with Aging (1992) (0)
Multiplexed detection of protein and phosphorylation variation in response to androgen withdrawal in LNCaP cells (2007) (0)
Symposium On Selected Clinical Syndromes Associated With Aging (1992) (0)
Basic research as an investment in the future. (1985) (0)
A Quest for Missing Proteins: update 2015 on Chromosome-Centric Human (2015) (0)
The ÃŸ-Caroteneand Retinol Efficacy Trial (CARET) for Chemoprevention of Lung Cancer in High Risk Populations: Smokers and Asbestos-exposed Workers1 (2006) (0)
Abstract 2214: An integrative approach to reveal driver gene fusions from paired end sequencing data in cancer (2010) (0)
Highlights of the HUPO Plasma Proteome Project: Creating a knowledge base for clinical assays (2005) (0)
Evaluation of Omics-Based Tests for Clinical Utility and Use (2012) (0)
Standard Guidelines for the Chromosome-Centric (2012) (0)
Blood metabolome predicts gut microbiome α-diversity in humans (2019) (0)
List of contributors (1986) (0)
Putting patients and families first. (2000) (0)
HANCOCK WS. GENOME-WIDE PROTEOMICS, CHROMOSOMECENTRIC HUMAN PROTEOME PROJECT (C-HPP), PART II (2014) (0)
Book Review:Regulatory Toxicology. Christopher P. Chengelis, Joseph F. Holson, Shayne C. Gad (1996) (0)
FIFTH INTERNATIONAL CONGRESS OF HUMAN GENETICS: DNA/RNA hybridization studies (1976) (0)
Report on the World Health Organization's ''Public Health Summit'' (1991) (0)
INTRODUCTION (1972) (0)
PUBLIC COMMENT ON OMB DRAFT RISK ASSESSMENT BULLETIN (2006) (0)
Introduction to Biomarkers (2012) (0)
Personal Dense Dynamic Data Clouds Connect Systems Biomedicine to Scientific Wellness. (2022) (0)
Modeling Dynamic Fluctuations in Type 1 Diabetes Progression: Quantifying β -cell variation after the appearance of islet-specific autoimmune responses (2015) (0)
Evaluation of Headache-Reply (1981) (0)
Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework (2017) (0)
Abstract 5118: Proteogenomics characterization of HPV-negative head and neck squamous cell carcinomas (2020) (0)
The Politics of Health Care (1980) (0)
Molecular neurogenetics (1981) (0)
Letter from Gilbert S. Omenn, Risk Assessment and Risk Management Commission (RAMC) to Thomas S. Foley (1997) (0)
Molecular Neurobiology: Molecular Approaches to Neurobiology . Ian R. Brown, Ed. Academic Press, New York, 1982. xii, 422 pp., illus. $49.50. Cell Biology. (1983) (0)
Prognostic Factors in Cancer, 3rd edition. By M. K. Gospodarowicz, B. O'Sullivan, L. H. Sobin (Eds.) (2006) (0)
Policy aspects of epidemiologic studies of possible health effects of electric and magnetic fields from power lines. (1991) (0)
Expansion of a novel endogenous retrovirus throughout the pericentromeres of modern humans (2015) (0)
INTRODUCTION (1972) (0)
INTRODUCTION (1972) (0)
Health services for tomorrow: Trends & issues: by Eveline M. Burns. Dunellen Publishing, New York, 1973. 226 pp. $5.95 (paper). (1977) (0)
Effects of Chronic Excess Salt Feeding: Demonstration of Normal Thyroid Function in Salt-Fed Dogs with Hypercholesterolemia 1 (1970) (0)
Adrenals in Ectopic ACTH Syndrome (1971) (0)
Book ReviewGenetics of Neurological and Psychiatric Disorders The Genetics of Neurological Disorders (1983) (0)
Contents, Vol. 5, 1974 (1971) (0)
Abstract LB-52: Integrative protein and transcriptomic analysis identified an EMT-associated secretory phenotype that correlates with metastasis and predicts survival in lung adenocarcinoma patients (2011) (0)
Users and Providers of the New Technologies (1988) (0)
N-Glycoproteomic Landscape of Human Lymphoid Cancers Reveals Novel Biomarkers and Potential Therapeutic Targets (2015) (0)
Book Review: Promoting Healthy Behavior: How Much Freedom? Whose Responsibility? (2001) (0)
Information Gathering Sessions and Speakers (2012) (0)
Heredity and environmental interactions. (1987) (0)
Abstract 2305: Identifying inhibitors of Epithelial-mesenchymal transition to prevent metastasis using global gene expression profile and a systems biology tool (2010) (0)
Ectopic pth production. (1970) (0)
What Every Reader Should Know About Studies Using Electronic Health Record Data but May Be Afraid to Ask (Preprint) (2020) (0)
HUMAN BEHAVIOR, GENES AND SOCIETY (1972) (0)
Committee Member and Staff Biographies (2012) (0)
Modeling the functional relationship network at the isoform level through heterogeneous data integration (2014) (0)
Genetics and alcoholism. Research strategies. (1987) (0)
Federal Policy Making for Biotechnology Executive Branch Office of Management and Budget (2002) (0)
Genomics and public health (2005) (0)
Familial reticuloendotheliosis with eosinophilia: a follow-up. (1971) (0)
P95 Human subjects review in long-term prevention trials: Recommendations from the caret experience (1997) (0)
In the Limelight (2001) (0)
Biomarker Discovery for Metastatic Disease (2009) (0)

This paper list is powered by the following services:

Other Resources About Gil Omenn

en.wikipedia.org

What Schools Are Affiliated With Gil Omenn?

Gil Omenn is affiliated with the following schools:

Gil Omenn's Academic­Influence.com Rankings

Gil Omenn's Degrees

Why Is Gil Omenn Influential?

Gil Omenn's Published Works

Published Works

Other Resources About Gil Omenn

What Schools Are Affiliated With Gil Omenn?

Gil Omenn's AcademicInfluence.com Rankings